Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1101

1.

CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.

Rodriguez JL, Thomas CC, Massetti GM, Duquette D, Avner L, Iskander J, Khoury MJ, Richardson LC.

MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1291-1294. doi: 10.15585/mmwr.mm6546a3.

2.

Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome.

Kacerovska D, Drlik L, Slezakova L, Michal M, Stehlik J, Sedivcova M, Hadravsky L, Kazakov DV.

Am J Dermatopathol. 2016 Dec;38(12):915-923.

PMID:
27870730
3.

Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.

Usha L, Dewdney SB, Buckingham LE.

JAMA. 2016 Jul 5;316(1):93-4. doi: 10.1001/jama.2016.8286. No abstract available.

PMID:
27380347
4.

[Lynch Syndrome -  the Pathologist's Diagnosis].

Dušek M, Hadravský L, Černá K, Stehlík J, Švajdler M, Kokošková B, Dubová M, Michal M, Daum O.

Klin Onkol. 2016;29(3):180-6. Czech.

PMID:
27296402
5.

Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test.

Alqahtani M, Grieu F, Carrello A, Amanuel B, Mashour M, Alattas R, Saleh K, Alsheikh A, Alqahtani S, Iacopetta B.

Asian Pac J Cancer Prev. 2016;17(4):1917-23.

6.

[Management and Nursing care for a patient with Lynch syndrome: A case report].

Pacheco-Pérez LA, Guevara Valtier MC.

Enferm Clin. 2016 Sep-Oct;26(5):321-4. doi: 10.1016/j.enfcli.2016.04.004. Spanish.

PMID:
27209158
7.

Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.

Tanakaya K, Yamaguchi T, Ishikawa H, Hinoi T, Furukawa Y, Hirata K, Saida Y, Shimokawa M, Arai M, Matsubara N, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Ishida H, Watanabe T, Sugihara K; for HNPCC Registry and Genetic Testing Project of the Japanese Society for Cancer of the Colon and Rectum..

Anticancer Res. 2016 Apr;36(4):1985-9.

PMID:
27069191
8.

The genetic prediction of risk for gynecologic cancers.

Randall LM, Pothuri B.

Gynecol Oncol. 2016 Apr;141(1):10-6. doi: 10.1016/j.ygyno.2016.03.007. Review.

PMID:
27016223
9.

Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol.

Taylor N, Long JC, Debono D, Williams R, Salisbury E, O'Neill S, Eykman E, Braithwaite J, Chin M.

BMC Health Serv Res. 2016 Mar 12;16:89. doi: 10.1186/s12913-016-1331-8.

10.

[Diagnosis and treatment of Lynch syndrome].

Seppälä T, Pylvänäinen K, Renkonen-Sinisalo L, Böhm J, Kuopio T, Järvinen HJ, Mecklin JP.

Duodecim. 2016;132(3):233-40. Review. Finnish.

PMID:
26951027
11.

Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.

Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S, Arnold J, Young JP, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Potter JD, DeRycke M, Lindor NM, Thibodeau SN, Baron JA, Win AK, Hopper JL, Jenkins MA, Buchanan DD; Colon Cancer Family Registry Cohort..

BMJ Open. 2016 Feb 19;6(2):e010293. doi: 10.1136/bmjopen-2015-010293.

12.

Mismatch repair deficiency testing in clinical practice.

Buza N, Ziai J, Hui P.

Expert Rev Mol Diagn. 2016;16(5):591-604. doi: 10.1586/14737159.2016.1156533. Review.

PMID:
26895074
13.

Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.

John AM, Schwartz RA.

J Am Acad Dermatol. 2016 Mar;74(3):558-66. doi: 10.1016/j.jaad.2015.09.074. Review.

PMID:
26892655
14.

Lynch Syndrome Screening in the Gynecologic Tract: Current State of the Art.

Mills AM, Longacre TA.

Am J Surg Pathol. 2016 Apr;40(4):e35-44. doi: 10.1097/PAS.0000000000000608. Review.

PMID:
26872009
15.

Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.

Patel SG, Ahnen DJ, Kinney AY, Horick N, Finkelstein DM, Hill DA, Lindor NM, MaCrae F, Lowery JT.

Am J Gastroenterol. 2016 Feb;111(2):285-93. doi: 10.1038/ajg.2015.397.

16.

Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies.

Ponti G, Tomasi A, Manfredini M, Pellacani G.

Gene. 2016 May 10;582(1):23-32. doi: 10.1016/j.gene.2016.01.053. Review.

PMID:
26850131
17.

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.

Hall MJ, Obeid EI, Schwartz SC, Mantia-Smaldone G, Forman AD, Daly MB.

Gynecol Oncol. 2016 Mar;140(3):565-74. doi: 10.1016/j.ygyno.2016.01.019. Review.

PMID:
26812021
18.

[A Family Affected by Lynch Syndrome Caused by MSH6 Germline Mutation].

Chika N, Kumamoto K, Suzuki O, Fukuchi M, Matsuzawa T, Kumagai Y, Ishibashi K, Eguchi H, Mochiki E, Ishida H.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2211-4. Japanese.

PMID:
26805314
19.

Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.

Kidambi TD, Blanco A, Van Ziffle J, Terdiman JP.

Fam Cancer. 2016 Apr;15(2):275-80. doi: 10.1007/s10689-016-9868-6.

PMID:
26781822
20.

Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes.

Singapore Cancer Network (SCAN) Cancer Genetics Workgroup..

Ann Acad Med Singapore. 2015 Oct;44(10):492-510.

Items per page

Supplemental Content

Loading ...
Support Center